Armata Pharmaceuticals, Inc.
(NYSE Amex Equities : ARMP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 5.22%219.110.0%$1919.42m
BIIBBiogen, Inc. -1.13%376.601.7%$1319.88m
SNSSSunesis Pharmaceuticals, Inc. -6.71%11.960.7%$836.05m
NVAXNovavax, Inc. 6.90%193.4879.8%$802.44m
AMGNAmgen, Inc. -0.44%239.191.3%$660.56m
BNTXBioNTech SE 3.28%233.520.0%$571.11m
VRTXVertex Pharmaceuticals, Inc. -0.25%187.231.9%$532.76m
GILDGilead Sciences, Inc. -0.71%66.881.0%$494.53m
REGNRegeneron Pharmaceuticals, Inc. -0.65%530.832.7%$385.91m
ILMNIllumina, Inc. 1.05%465.893.5%$353.04m
ALXNAlexion Pharmaceuticals, Inc. -0.51%179.742.0%$338.18m
OCGNOcugen, Inc. -4.80%7.050.0%$326.46m
TXG10X Genomics, Inc. 1.07%200.000.0%$179.25m
EXASEXACT Sciences Corp. 1.18%129.1718.1%$178.49m
TECHBio-Techne Corp. 0.55%442.624.5%$164.74m

Company Profile

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.